Cardiac Biotech Solutions Inc. (CBSC)
- Previous Close
0.0301 - Open
0.0301 - Bid 0.0340 x --
- Ask 0.0390 x --
- Day's Range
0.0301 - 0.0390 - 52 Week Range
0.0210 - 0.1490 - Volume
30,000 - Avg. Volume
74,168 - Market Cap (intraday)
6.294M - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cardiac Biotech Solutions Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide enhanced compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevada.
cbscientificinc.comRecent News: CBSC
View MorePerformance Overview: CBSC
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBSC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBSC
View MoreValuation Measures
Market Cap
6.29M
Enterprise Value
6.28M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
97.40
Price/Book (mrq)
--
Enterprise Value/Revenue
103.44
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
50.37k
Net Income Avi to Common (ttm)
-640.55k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
4.67k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--